Suppr超能文献

抗菌药物对巴西奴卡菌的体外和体内活性

In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.

作者信息

Gomez-Flores Alejandra, Welsh Oliverio, Said-Fernández Salvador, Lozano-Garza Gerardo, Tavarez-Alejandro Roman Erick, Vera-Cabrera Lucio

机构信息

Servicio de Dermatología, Hospital Universitario "José E. González," Centro de Investigación Biomédica del Noreste, IMSS, Monterrey, N.L., México.

出版信息

Antimicrob Agents Chemother. 2004 Mar;48(3):832-7. doi: 10.1128/AAC.48.3.832-837.2004.

Abstract

In Mexico mycetomas are mostly produced by Nocardia brasiliensis, which can be isolated from about 86% of cases. In the present work, we determined the sensitivities of 30 N. brasiliensis strains isolated from patients with mycetoma to several groups of antimicrobials. As a first screening step we carried out disk diffusion assays with 44 antimicrobials, including aminoglycosides, cephalosporins, penicillins, quinolones, macrolides, and some others. In these assays we observed that some antimicrobials have an effect on more than 66% of the strains: linezolid, amikacin, gentamicin, isepamicin, netilmicin, tobramycin, minocycline, amoxicillin-clavulanic acid, piperacillin-tazobactam, nitroxolin, and spiramycin. Drug activity was confirmed quantitatively by the broth microdilution method. Amoxicillin-clavulanic acid, linezolid, and amikacin, which have been used to treat patients, were tested in an experimental model of mycetoma in BALB/c mice in order to validate the in vitro results. Linezolid showed the highest activity in vivo, followed by the combination amoxicillin-clavulanic acid and amikacin.

摘要

在墨西哥,足菌肿大多由巴西诺卡菌引起,约86%的病例可分离出该菌。在本研究中,我们测定了从足菌肿患者中分离出的30株巴西诺卡菌对几类抗菌药物的敏感性。作为第一步筛选,我们用44种抗菌药物进行了纸片扩散试验,这些抗菌药物包括氨基糖苷类、头孢菌素类、青霉素类、喹诺酮类、大环内酯类以及其他一些药物。在这些试验中,我们观察到一些抗菌药物对超过66%的菌株有作用:利奈唑胺、阿米卡星、庆大霉素、异帕米星、奈替米星、妥布霉素、米诺环素、阿莫西林 - 克拉维酸、哌拉西林 - 他唑巴坦、硝咯喹啉和螺旋霉素。通过肉汤微量稀释法对药物活性进行了定量确认。为了验证体外试验结果,在BALB/c小鼠足菌肿实验模型中对已用于治疗患者的阿莫西林 - 克拉维酸、利奈唑胺和阿米卡星进行了测试。利奈唑胺在体内显示出最高活性,其次是阿莫西林 - 克拉维酸组合和阿米卡星。

相似文献

1
In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.
Antimicrob Agents Chemother. 2004 Mar;48(3):832-7. doi: 10.1128/AAC.48.3.832-837.2004.
2
In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.
Antimicrob Agents Chemother. 2001 Dec;45(12):3629-30. doi: 10.1128/AAC.45.12.3629-3630.2001.
6
Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.
PLoS Negl Trop Dis. 2008 Sep 10;2(9):e289. doi: 10.1371/journal.pntd.0000289.
7
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.
J Clin Microbiol. 2012 Apr;50(4):1270-80. doi: 10.1128/JCM.00994-11. Epub 2012 Jan 4.
9
In vitro activities of new antimicrobials against Nocardia brasiliensis.
Antimicrob Agents Chemother. 2004 Feb;48(2):602-4. doi: 10.1128/AAC.48.2.602-604.2004.
10
In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.
Antimicrob Agents Chemother. 2008 Apr;52(4):1549-50. doi: 10.1128/AAC.00148-08. Epub 2008 Feb 19.

引用本文的文献

3
Invasive Nocardiosis: Disease Presentation, Diagnosis and Treatment - Old Questions, New Answers?
Infect Drug Resist. 2020 Dec 22;13:4601-4613. doi: 10.2147/IDR.S249761. eCollection 2020.
4
Clinical characteristics and treatment of actinomycetoma in northeast Mexico: A case series.
PLoS Negl Trop Dis. 2020 Feb 25;14(2):e0008123. doi: 10.1371/journal.pntd.0008123. eCollection 2020 Feb.
5
Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil.
PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005301. doi: 10.1371/journal.pntd.0005301. eCollection 2017 Feb.
6
Disseminated nocardiosis caused by in an immunocompetent host: A case report and literature review.
Exp Ther Med. 2016 Nov;12(5):3339-3346. doi: 10.3892/etm.2016.3755. Epub 2016 Sep 28.
7
In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis.
PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004022. doi: 10.1371/journal.pntd.0004022. eCollection 2015.
8
Mycetoma medical therapy.
PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3218. doi: 10.1371/journal.pntd.0003218. eCollection 2014 Oct.
9
Long-term treatment of persistent disseminated Nocardia cyriacigeorgica infection.
Braz J Infect Dis. 2014 Sep-Oct;18(5):556-60. doi: 10.1016/j.bjid.2014.03.007. Epub 2014 May 13.
10
Nocardiosis in transplant recipients.
Eur J Clin Microbiol Infect Dis. 2014 May;33(5):689-702. doi: 10.1007/s10096-013-2015-5. Epub 2013 Nov 23.

本文引用的文献

2
[Quinolones].
Enferm Infecc Microbiol Clin. 2003 May;21(5):261-7; quiz 268, 272. doi: 10.1016/s0213-005x(03)72932-2.
3
[Oxazolidinones and glycopeptides].
Enferm Infecc Microbiol Clin. 2003 Mar;21(3):157-64; quiz 165, 169. doi: 10.1016/s0213-005x(03)72907-3.
4
Clinical experience with linezolid for the treatment of nocardia infection.
Clin Infect Dis. 2003 Feb 1;36(3):313-8. doi: 10.1086/345907. Epub 2003 Jan 13.
6
In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.
Antimicrob Agents Chemother. 2001 Dec;45(12):3629-30. doi: 10.1128/AAC.45.12.3629-3630.2001.
7
In vitro activities of linezolid against multiple Nocardia species.
Antimicrob Agents Chemother. 2001 Apr;45(4):1295-7. doi: 10.1128/AAC.45.4.1295-1297.2001.
8
Lymphocutaneous Nocardia brasiliensis infection: a pediatric case cured with amoxicilin/clavulanate.
Pediatr Infect Dis J. 2000 Oct;19(10):1023-5. doi: 10.1097/00006454-200010000-00022.
9
Aminoglycosides: nephrotoxicity.
Antimicrob Agents Chemother. 1999 May;43(5):1003-12. doi: 10.1128/AAC.43.5.1003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验